CD8A and neoplasm: As cross-priming of adaptive antitumor immunity by tumor-associated antigens (TAAs) is crucial for inducing the systemic antitumor effect of RT 32, we hypothesized that adoptive cell transfer (ACT) of TAA-primed CD8+ T cells would synergize with RT to trigger systemic antitumor reactions.